Evidence map›Paper›PMID 36179541›Full record

ArticleLung cancer (Amsterdam, Netherlands)2022

Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme.

Jennifer L Dickson, Helen Hall, Carolyn Horst, Sophie Tisi, Priyam Verghese, Sarah Worboys, Andrew Perugia, James Rusius, Anne-Marie Mullin, Jonathan Teague and 14 more

Abstract read
In one paragraph

Article in Lung cancer (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Observational
  7. Article
  8. Article
  9. Article
  10. What should the role of primary care be in lung cancer screening?The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Jennifer L DicksonLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Helen HallLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Carolyn HorstLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Sophie TisiLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Priyam VergheseLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Sarah WorboysJames Wigg GP Practice, London, UK.
Andrew PerugiaNOCLOR Research Support, London, UK.
James RusiusNOCLOR Research Support, London, UK.
Anne-Marie MullinCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Jonathan TeagueCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Laura FarrellyCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Vicky BowyerUniversity College London Hospitals NHS Foundation Trust, London, UK.
Kylie GyertsonUniversity College London Hospitals NHS Foundation Trust, London, UK.
Fanta BojangUniversity College London Hospitals NHS Foundation Trust, London, UK.
Claire LevermoreUniversity College London Hospitals NHS Foundation Trust, London, UK.
Tania AnastasiadisTower Hamlets Clinical Commissioning Group, London, UK.
John McCabeLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Anand DevarajDepartment of Radiology, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College, London, UK.
Arjun NairUniversity College London Hospitals NHS Foundation Trust, London, UK.
Neal NavaniLungs for Living Research Centre, UCL Respiratory, University College London, London, UK; University College London Hospitals NHS Foundation Trust, London, UK.
Allan HackshawCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Samantha L QuaifeWolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, UK; University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: s.janes@ucl.ac.uk.
SUMMIT consortium

Funding

Cancer Research UK 24460Cancer Research UK 28706Cancer Research UK C50664/A24460Cancer Research UK EDDCPGM/100002Medical Research Council MR/T02481X/1Wellcome Trust 209553Wellcome Trust WT107963AIA
6 · The paper itself

Abstract

Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption. Primary care smoking data could guide LCS invitation and eligibility assessment. We present observational data from the SUMMIT Study, where individual self-reported smoking status was concordant with primary care records in 75.3%. However, 10.3% demonstrated inconsistencies between historic and most recent smoking status documentation. Quantified tobacco consumption was frequently missing, precluding direct LCS eligibility assessment. Primary care recorded "ever-smoker" status, encompassing both recent and historic documentation, can be used to target LCS invitation. Identifying those with missing or erroneous "never-smoker" smoking status is crucial for equitable invitation to LCS.

Indexed as

Early Detection of CancerLung NeoplasmsElectronic Health RecordsHumansMass ScreeningPrimary Health CareTomography, X-Ray ComputedLung cancerLung cancer screening

Identifiers

PMID36179541
PMCPMC10533413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.